Bay Street News

Enovis™ to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual Meeting

WILMINGTON, DE, Feb. 12, 2024 (GLOBE NEWSWIRE) — Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology company, will showcase its latest technologies across the orthopedic care continuum at the American Academy of Orthopedic Surgeons Annual Meeting 2024. In addition, the Company will present itself as a newly integrated company following the acquisition of orthopedic leader LimaCorporate S.p.A (“Lima”).

“Enovis has a lot to be excited about in 2024. In our Surgical business, the addition of Lima brings great technologies, capabilities and a product portfolio with demonstrated clinical excellence around the world. Our newly combined sales channel has size, scale and global market access which is extremely powerful,” stated Louie Vogt, Group President of Enovis Recon. “2024 will also be a banner year for product innovation and our ability to improve patient outcomes. We’re launching more new products than ever before with significant introductions across shoulders, knees and hips.”

With the addition of Lima, Enovis will present its extensive and newly integrated portfolio of implant technologies, pre- and post-operative care solutions and digital care resources that help clinicians provide the best care to their patients:

Visit AAOS booth #1827 or www.enovis.com to learn how Enovis is developing innovative medical technology that continues to revolutionize the orthopedic industry.

About Enovis
Enovis Corporation (NYSE: ENOV) is an innovation-driven, medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services, and integrated technologies fuels active lifestyles in orthopedics and beyond. For more information about Enovis, please visit www.enovis.com

Media Contact

Katie Sweet

Vice President, Corporate Communications

Katie.Sweet@enovis.com 

References

  1. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1924521/AJRR reference of Linear longevity
  2. Report on file with Enovis Surgical, IRPD-2023-0018
  3. Melinda K. Harman, Stephanie J. Bonin, Chris J. Leslie, Scott A. Banks, and W. Andrew Hodge, “Total Knee Arthroplasty Designed to Accommodate the Presence or Absence of the Posterior Cruciate Ligament,” Advances in Orthopedics, vol. 2014, Article ID 178156, 8 pages, 2014.
  4. Meneghini, R. M., Deckard, E. R., Ishmael, M. K., & Ziemba-Davis, M. (2017). A dual-pivot pattern simulating native knee kinematics optimizes functional outcomes after total knee arthroplasty. The Journal of Arthroplasty, 32(10), 3009–3015. https://doi.org/10.1016/j.arth.2017.04.050
  5. Sandberg, Rory, et al. “Dual-pivot bearings improve ambulation and promote increased activity levels in Total knee arthroplasty: A match-controlled retrospective study.” The Knee 26.6 (2019): 1243-1249.


Bay Street News